Target intelligence / Profile preview

U3 small nucleolar RNA (SNORD3A (U3))

Target
SNORD3A (U3)
Molecular classification
Small nucleolar RNA (snoRNA), C/D box snoRNA, Noncoding RNA
01

Overview

U3 small nucleolar RNA (SNORD3A, also called U3) is a highly conserved noncoding RNA found in the nucleolus of eukaryotic cells[1][5]. It is a member of the C/D box snoRNA family, but unlike most C/D box snoRNAs, U3 does not guide 2'-O-methylation of ribosomal RNA. Instead, it is essential for early cleavage steps in pre-rRNA processing, acting as a guide for assembling snoRNP complexes involved in the maturation of ribosomal RNA—a critical step for ribosome biogenesis[1][5]. U3 snoRNA achieves its function by forming complexes with specific proteins (fibrillarin/Nop1p, NOP56, NOP58, SNU13/15.5 kD protein)[1][5]. It is localized to the nucleolus and is required for proper processing and assembly of eukaryotic ribosomes[5]. U3 snoRNA is not classified as a receptor, enzyme, or transporter, nor is it a direct drug target. Its disruption can affect cell growth and division due to faulty ribosome synthesis, underlining its fundamental role in cellular physiology. However, its aberrant expression is not currently linked as a primary driver of specific human diseases or as a therapeutic target.

Other names
SNORD3AU3RNU3U3 snoRNA AU3 small nucleolar RNA A
02

Mechanism of action

No drugs are known to target SNORD3A/U3, so mechanisms of drug action do not apply.

03

Biological functions

Pre-rRNA processing, specifically directing cleavage of pre-rRNA substrates during ribosome biogenesisRNA modification: most C/D box snoRNAs direct 2'-O-methylation, but U3 does not; instead, U3 functions uniquely in rRNA processingScaffold for ribonucleoprotein (snoRNP) complex assemblyNucleolar localization and RNA-based catalysis
04

Disease associations

Other. While aberrant processing or expression of snoRNAs can be implicated in cancer and other diseases, specific disease associations for SNORD3A/U3 are not widely reported. General importance in cell growth and ribosome biogenesis means dysregulation may contribute to disease but direct roles are not established.

Beyond the preview

Go deeper on U3 small nucleolar RNA (SNORD3A (U3)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U3 small nucleolar RNA (SNORD3A (U3)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call